MAIA Biotechnology, Inc.
MAIA
$1.33
$0.021.53%
AMEX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -21.82% | 40.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.68% | 60.98% | |||
| Operating Income | -19.68% | -60.98% | |||
| Income Before Tax | -24.71% | -75.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -24.71% | -75.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -24.71% | -75.53% | |||
| EBIT | -19.68% | -60.98% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 7.24% | -44.36% | |||
| Normalized Basic EPS | 7.26% | -44.43% | |||
| EPS Diluted | 7.24% | -44.36% | |||
| Normalized Diluted EPS | 7.26% | -44.43% | |||
| Average Basic Shares Outstanding | 34.46% | 21.56% | |||
| Average Diluted Shares Outstanding | 34.46% | 21.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||